Granulocyte Colony-Stimulating Factor clinical trials
Counted the way a researcher would: Granulocyte Colony-Stimulating Factor with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Granulocyte Colony-Stimulating Factor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Granulocyte Colony-Stimulating Factor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
In one entry with another drug
Given together, or one or the other
Studies by the year they started
179 studies that test it; most in 2004 (14)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1995 | 1 |
| 1996 | 2 |
| 1998 | 1 |
| 1999 | 2 |
| 2000 | 4 |
| 2001 | 8 |
| 2002 | 6 |
| 2003 | 8 |
| 2004 | 14 |
| 2005 | 9 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 9 |
| 2011 | 6 |
| 2012 | 8 |
| 2013 | 8 |
| 2014 | 10 |
| 2015 | 7 |
| 2016 | 8 |
| 2017 | 7 |
| 2018 | 9 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 8 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 22 · Other 157
M.D. Anderson Cancer Center (11) · Genzyme, a Sanofi Company (10) · St. Jude Children's Research Hospital (7) · Northwestern University (6) · Washington University School of Medicine (5) · Masonic Cancer Center, University of Minnesota (5) · Chinese PLA General Hospital (4) · Post Graduate Institute of Medical Education and Research, Chandigarh (4)
Often tested with
Tested in the same studies.
Cyclophosphamide (36) · Fludarabine (24) · Plerixafor (23) · Cytarabine (21) · Filgrastim (16) · Mesna (14) · Melphalan (13) · Mycophenolic Acid (12)
Related medicines
As reviewed, each with the page that says it.
- Filgrastim is a recombinant medicine of it, counted here with related medicines source
- Lenograstim is a recombinant medicine of it, counted here with related medicines source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 9
Studies that test Granulocyte Colony-Stimulating Factor.
- Dec 2026G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell TransplantationPhase 2 · Fudan University
- Dec 2026Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell LymphomaPhase 2 · Canadian Cancer Trials Group
- Jan 2027Alpha/Beta TCD HCT in Patients With Inherited BMF DisordersPhase 2 · Masonic Cancer Center, University of Minnesota
- Jan 2027G-CSF After Chemo-radiation in Patients With GlioblastomaPhase 2 · Massachusetts General Hospital
- Mar 2027CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy DonorsNot applicable · First Affiliated Hospital of Zhejiang University
- May 2027Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaPhase 2 · City of Hope Medical Center
- Jun 2027Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet DisorderPhase 1 · M.D. Anderson Cancer Center
- Sep 2027Auto Stem Cell Transplant for Lymphoma PatientsPhase 2 · Masonic Cancer Center, University of Minnesota
- Nov 2027A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)Phase 1/2 · GlaxoSmithKline
Studies
Open first, then newest update. How each study uses Granulocyte Colony-Stimulating Factor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 179
- Auto Stem Cell Transplant for Lymphoma PatientsRecruitingPhase 2Masonic Cancer Center, University of MinnesotaNCT03125642Written as G-CSF
- CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy DonorsRecruitingNot applicableFirst Affiliated Hospital of Zhejiang UniversityNCT07423728Written as G-CSF (Granulocyte colony-stimulating factor)
- G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell TransplantationRecruitingPhase 2Fudan UniversityNCT07362810Written as G-CSF+IL-11
- Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket TrialRecruitingPhase 2Assistance Publique - Hôpitaux de ParisNCT06381661Written as G-CSF filgrastim
- A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)RecruitingPhase 1/2GlaxoSmithKlineNCT07602777Written as G-CSF
- Haploidentical HCT for Severe Aplastic AnemiaRecruitingPhase 2St. Jude Children's Research HospitalNCT04558736Written as G-CSF
- Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma PatientsRecruitingPhase 3Guangzhou Gloria Biosciences Co., Ltd.NCT06514508Written as Motixafortide+G-CSF
- Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AMLNot yet recruitingPhase 3Ruijin HospitalNCT07735117Written as Granulocyte Colony-Stimulating Factor(G-CSF)
- Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic DonorsRecruitingPhase 3First Affiliated Hospital of Zhejiang UniversityNCT07692841Written as Single-dose Granulocyte colony-stimulating factor (G-CSF)
- Intrauterine G-CSF Infusion for Thin EndometriumNot yet recruitingPhase 3Nanjing UniversityNCT07692672Written as Granulocyte Colony-Stimulating Factor(G-CSF)
- Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel ChemotherapyRecruitingPhase 4Ottawa Hospital Research InstituteNCT05753618Written as Granulocyte Colony-Stimulating Factor (G-CSF)
- Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet DisorderRecruitingPhase 1M.D. Anderson Cancer CenterNCT06414889Written as G-CSF (filgrastim or biosimilar)
- A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML PatientsRecruitingPhase 2Chinese PLA General HospitalNCT06928376Written as Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
- G-CSF After Chemo-radiation in Patients With GlioblastomaRecruitingPhase 2Massachusetts General HospitalNCT06649851Written as Granulocyte Colony Stimulating Factor (G-CSF)
- VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm TrialRecruitingPhase 2Beijing 302 HospitalNCT07514832Written as Venetoclax, Azacitidine, Cytarabine, Idarubicin, G-CSF
- Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic LeukemiaRecruitingPhase 2Chinese PLA General HospitalNCT07512700Written as CACAG+VEN
- Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaRecruitingPhase 2Chinese PLA General HospitalNCT06084819Written as Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
- Alpha/Beta TCD HCT in Patients With Inherited BMF DisordersRecruitingPhase 2Masonic Cancer Center, University of MinnesotaNCT03579875Written as G-CSF
- Lung and Bone Marrow Transplantation for Lung and Bone Marrow FailureRecruitingPhase 1/2Paul SzabolcsNCT03500731Written as G-CSF
- Comparison of G-CSF & Antibiotics Versus Antibiotics Alone in Resolution of Febrile NeutropeniaNot yet recruitingPhase 4King Edward Medical UniversityNCT06988826Written as G-CSF
See all 179 studies that test Granulocyte Colony-Stimulating Factor →
Given beside what is tested · 146 — Granulocyte Colony-Stimulating Factor is usual care or a partner of the new treatment
- Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS TumorsRecruitingPhase 2St. Jude Children's Research HospitalNCT06528691Written as G-CSF
- A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)RecruitingPhase 2/3Merck Sharp & Dohme LLCNCT05139017Written as Granulocyte Colony-Stimulating Factor (G-CSF)
- Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk NeuroblastomaRecruitingPhase 2Masonic Cancer Center, University of MinnesotaNCT02605421Written as Granulocyte colony stimulating factor
- CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantRecruitingPhase 2City of Hope Medical CenterNCT06059391Written as Granulocyte Colony-Stimulating Factor
- Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple MyelomaRecruitingPhase 1Hackensack Meridian HealthNCT03909412Written as Granulocyte Colony-Stimulating Factor
- Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRecruitingPhase 1Kura Oncology, Inc.NCT06001788Written as Granulocyte colony-stimulating factor
- Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple MyelomaNot yet recruitingPhase 1University of California, DavisNCT07759102Written as Granulocyte Colony-Stimulating Factor
- Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple MyelomaRecruitingPhase 2M.D. Anderson Cancer CenterNCT06207799Written as G-CSF
- Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.RecruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT07002827Written as G-CSF
- Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid MalignanciesRecruitingPhase 1University of Alabama at BirminghamNCT07044544Written as G-CSF
- The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood TransplantationNot yet recruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT07441967Written as G-CSF
- Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast CancerNot yet recruitingPhase 2MedSIRNCT07367178Written as G-CSF (Granulocyte colony-stimulating factor)
- Autologous Stem Cell Transplantation for Crohn's DiseaseRecruitingPhase 1/2Paul SzabolcsNCT00692939Written as G-CSF
- Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for LymphomaRecruitingPhase 3The Affiliated People's Hospital of Ningbo UniversityNCT06520163Written as G-CSF
- HSCT for Patients With Fanconi Anemia Using Risk-Adjusted ChemotherapyRecruitingPhase 2Children's Hospital Medical Center, CincinnatiNCT02143830Written as G-CSF
- CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AMLNot yet recruitingPhase 4Nanfang Hospital, Southern Medical UniversityNCT06763666Written as G-CSF
- VHAG in Treating R/R T-ALL/LBLRecruitingPhase 2First Affiliated Hospital of Zhejiang UniversityNCT06742463Written as G-CSF
- Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid LeukemiaRecruitingPhase 3Shanxi Bethune HospitalNCT05726110Written as Granulocyte Colony-Stimulating Factor
- Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT MutationRecruitingPhase 2Children's Hospital of Soochow UniversityNCT06316960Written as Granulocyte Colony-Stimulating Factor
- Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma PatientsRecruitingPhase 3The Affiliated People's Hospital of Ningbo UniversityNCT06520176Written as G-CSF
Showing 20 of 146.
As the comparator · 15 — what is tested is compared with Granulocyte Colony-Stimulating Factor
- G-CSF In Neonatal Sepsis With NeutropeniaNot yet recruitingNot applicableUniversity of Health Sciences LahoreNCT07888829Written as Granulocyte-colony stimulating factor (G-CSF)
- Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AMLRecruitingPhase 1/2Washington University School of MedicineNCT06158828Written as Granulocyte Colony-Stimulating Factor
- The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant MobilizationNot yet recruitingEarly Phase 1Zhongnan HospitalNCT05970185Written as G-CSF
- A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) MutationCompletedPhase 3Astellas Pharma IncNCT03182244Written as G-CSF
- Specialized Blood Cell Transplants for Cancers of the Blood and Bone MarrowCompletedPhase 2National Heart, Lung, and Blood Institute (NHLBI)NCT00003838Written as G-CSF
- GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCTStatus unknownPhase 2/3Post Graduate Institute of Medical Education and Research, ChandigarhNCT03911037Written as G-CSF
- Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate CancerTerminatedPhase 1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT02478125Written as G-CSF
- G-CSF in Decompensated Cirrhosis: an Open Label TrialStatus unknownPhase 2/3Post Graduate Institute of Medical Education and Research, ChandigarhNCT03415698Written as G-CSF
- Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML PatientsStatus unknownPhase 2Shandong UniversityNCT03045627Written as G-CSF
- Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal AngioplastyStatus unknownPhase 1Shanghai 10th People's HospitalNCT02915796Written as G-CSF
- Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)CompletedPhase 3Carelon ResearchNCT00627393Written as G-CSF/dexamethasone
- Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced NeutropeniaCompletedPhase 3Dong-A ST Co., Ltd.NCT01674855Written as G-CSF
- Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced NeutropeniaCompletedPhase 2Dong-A ST Co., Ltd.NCT01923545Written as G-CSF
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)WithdrawnPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00230035Written as Growth colony stimulating factor (G-CSF)
- A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb IschemiaStatus unknownPhase 1/2Beike Biotech India Pvt.ltdNCT00922389Written as G-CSF